lobbying_activities: 2687882

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2687882	f77ff540-32d3-4b2b-bf38-6a930fc75da9	Q3	BROYDRICK & ASSOCIATES	7268	EXELA PHARMA SCIENCES	2021	third_quarter	PHA	Drug shortages and FDA approval, USTR acceptance.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2021-10-19T06:35:15.933000-04:00